Replimune Group, Inc.
For the period ended Mar 31, 2025. Filed May 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 22, 2025
REPL$22.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated balance sheets F-
CONSOLIDATED BALANCE SHEETS
| March 31,2025 | March 31,2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $111,119 | $74,457 |
| Short-term investments | 372,685 | 346,211 |
| Research and development incentives receivable | 3,725 | 4,922 |
| Prepaid expenses and other current assets | 8,351 | 8,077 |
| Total current assets | 495,880 | 433,667 |
| Property, plant and equipment, net | 13,739 | 10,483 |
| Restricted cash | 1,703 | 1,700 |
| Other non-current assets | 1,200 | — |
| Right-to-use asset – operating leases | 3,998 | 4,635 |
| Right-to-use asset – financing leases | 34,808 | 37,237 |
| Total assets | $551,328 | $487,722 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $12,463 | $2,578 |
| Accrued expenses and other current liabilities | 45,916 | 33,981 |
| Operating lease liabilities, current | 1,184 | 1,161 |
| Financing lease liabilities, current | 2,799 | 2,718 |
| Total current liabilities | 62,362 | 40,438 |
| Operating lease liabilities, non-current | 3,076 | 3,771 |
| Financing lease liabilities, non-current | 22,729 | 23,410 |
| Long term debt, net of discount | 46,377 | 44,809 |
| Other liabilities, non-current | 941 | 786 |
| Total liabilities | $135,485 | $113,214 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2025 and March 31, 2024; 77,085,024 and 61,415,105 shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively | 77 | 61 |
| Additional paid-in capital | 1,358,897 | 1,070,874 |
| Accumulated deficit | (948,579) | (701,282) |
| Accumulated other comprehensive income | 5,448 | 4,855 |
| Total stockholders’ equity | 415,843 | 374,508 |
| Total liabilities and stockholders’ equity | $551,328 | $487,722 |
F - 4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.